Literature DB >> 6608697

Measurement of vitamin D metabolites in anephric subjects.

M J Jongen, W J van der Vijgh, P Lips, J C Netelenbos.   

Abstract

Circulating concentrations of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D were measured in 21 anephric subjects. 13 subjects had no therapy with vitamin D, dihydrotachysterol or 1 alpha-hydroxyvitamin D3. In 7 subjects of this group 1,25-dihydroxyvitamin D was undetectable (less than 5 pmol/l). In the other 6 patients concentrations ranged from 10 to 43 pmol/l (reference value 111 +/- 33 pmol/l). All subjects taking high doses of vitamin D showed detectable 1,25-dihydroxyvitamin D concentrations in the same range. Dihydrotachysterol therapy caused spuriously high '1,25-dihydroxyvitamin D' values, probably by interference of a metabolite of dihydrotachysterol in our assay. In subjects on vitamin D or dihydrotachysterol therapy 25-hydroxyvitamin D concentrations were significantly elevated (314 +/- 146 nmol/l and 98 +/- 19 nmol/l, respectively; reference value 52 +/- 22 nmol/l). Concentrations of 24,25-dihydroxyvitamin D were only measured in subjects without vitamin D2 intake. In general very low but detectable concentrations were found. One subject on a high dose of vitamin D3 showed a 24,25-dihydroxyvitamin D3 concentration of 10.2 nmol/l (reference value 4.4 +/- 2.9 nmol/l). Our results therefore confirm earlier reports on extrarenal synthesis of 24,25-dihydroxyvitamin D and suggest that there may be extrarenal production of 1,25-dihydroxyvitamin D as well.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608697     DOI: 10.1159/000183159

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

2.  Differences in the bioavailability of dihydrotachysterol preparations.

Authors:  R Koytchev; R G Alken; M Vagaday; U Kunter; V Kirkov
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

3.  Metabolic consequences of bilateral nephrectomy.

Authors:  G R Catto; N Muirhead
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-21

4.  Residual urinary output in high body mass index individuals on chronic hemodialysis: A disregarded life vest?

Authors:  Hernán Trimarchi; María S Raña; Alejandra Karl; José Andrews; Mariana Dicugno; Vanesa Pomeranz; Pablo Young; Mariano Forrester; Mirta Alonso; Fernando Lombi; Alexis Muryan
Journal:  World J Nephrol       Date:  2014-11-06

5.  Synthesis of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by calvarial cells. Characterization of the enzyme systems.

Authors:  J E Puzas; R T Turner; G A Howard; J S Brand; D J Baylink
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  Association of serum 25(OH) vitamin D3 concentration with severity of multiple sclerosis.

Authors:  Ali Amini Harandi; Saeed Shahbeigi; Hosein Pakdaman; Seyed-Mohammad Fereshtehnejad; Elham Nikravesh; Roghie Jalilzadeh
Journal:  Iran J Neurol       Date:  2012

7.  Vitamin d3 concentration correlates with the severity of multiple sclerosis.

Authors:  Saeed Shahbeigi; Hossein Pakdaman; Seyed-Mohammad Fereshtehnejad; Elham Nikravesh; Nazanin Mirabi; Ghazal Jalilzadeh
Journal:  Int J Prev Med       Date:  2013-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.